|
|
||||||||
From the Stroke Service of the Neurology Department (Drs. OliveiraFilho, Ezzeddine, Segal, Buonanno, Rordorf, Schwamm, Koroshetz, and McDonald), Medicine Department (Dr. Chang), and Neurosurgery Department (Dr. Ogilvy), Massachusetts General Hospital, and Harvard Medical School, Boston.
Address correspondence and reprint requests to Dr. Colin T. McDonald, Department of Neurology, Blake 1291, (Neurocritical Care Unit), Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114; e-mail: mcdonald{at}helix.mgh.harvard.edu
OBJECTIVE: To investigate the causes of fever in subarachnoid hemorrhage (SAH) and examine its relationship to outcome.
BACKGROUND: Fever adversely affects outcome in stroke. Patients with SAH are at risk for cerebral ischemia due to vasospasm (VSP). In these patients, fever may be both caused by, and potentiate, VSP-mediated brain injury.
METHODS: The authors prospectively studied patients admitted to a neurologic intensive care unit with nontraumatic SAH, documenting HuntHess grade, Fisher group, Glasgow Coma Score, bacterial culture data, daily transcranial Doppler mean velocities, and maximum daily temperatures. Patients were classified as febrile (temperature above 38.3 °C for at least 2 consecutive days) or afebrile (no fever or isolated episodes of temperature above 38.3 °C). VSP was verified by either transcranial Doppler or angiographic criteria. Rankin scale scores on discharge were dichotomized into good (0 to 2) or poor (3 to 6) outcomes.
RESULTS: Ninety-two consecutive patients were studied. Thirty-eight patients were classified as febrile. No source for infection was found in 10 of 38 (26%) patients. In a multivariate analysis, three variables independently predicted fever occurrence: ventriculostomy (OR, 8.5 [CI, 2.4 to 29.7]), symptomatic VSP (OR, 5.0 [CI, 1.03 to 24.5]), and older age (OR, 1.75 per 10 years [CI, 1.02 to 3.0]). Poor outcome was related to fever (OR, 1.4 per each day febrile [CI, 1.1 to 1.88]), older age (OR, 1.64 per 10 years [CI, 1.04 to 2.58]), and intubation (OR, 21.8 [CI, 5.6 to 84.5]).
CONCLUSION: Fever in SAH is associated with vasospasm and poor outcome independently of hemorrhage severity or presence of infection.
This article has been cited by other articles:
![]() |
G. Broessner, R. Beer, P. Lackner, R. Helbok, M. Fischer, B. Pfausler, J. Rhorer, L. Kuppers-Tiedt, D. Schneider, and E. Schmutzhard Prophylactic, Endovascularly Based, Long-Term Normothermia in ICU Patients With Severe Cerebrovascular Disease: Bicenter Prospective, Randomized Trial Stroke, December 1, 2009; 40(12): e657 - e665. [Abstract] [Full Text] [PDF] |
||||
![]() |
G J E Rinkel and C J M Klijn Prevention and treatment of medical and neurological complications in patients with aneurysmal subarachnoid haemorrhage Practical Neurology, August 1, 2009; 9(4): 195 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Reaven, J. E. Lovett, and S. E. Funk Brain Injury and Fever: Hospital Length of Stay and Cost Outcomes J Intensive Care Med, March 1, 2009; 24(2): 131 - 139. [Abstract] [PDF] |
||||
![]() |
N. Badjatia, E. Strongilis, E. Gordon, M. Prescutti, L. Fernandez, A. Fernandez, M. Buitrago, J. M. Schmidt, N. D. Ostapkovich, and S. A. Mayer Metabolic Impact of Shivering During Therapeutic Temperature Modulation: The Bedside Shivering Assessment Scale Stroke, December 1, 2008; 39(12): 3242 - 3247. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Greer, S. E. Funk, N. L. Reaven, M. Ouzounelli, and G. C. Uman Impact of Fever on Outcome in Patients With Stroke and Neurologic Injury: A Comprehensive Meta-Analysis Stroke, November 1, 2008; 39(11): 3029 - 3035. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A Rabinstein and K. Sandhu Non-infectious fever in the neurological intensive care unit: incidence, causes and predictors J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1278 - 1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S.F. Ling More heat to treat fever in subarachnoid hemorrhage? Neurology, March 27, 2007; 68(13): 973 - 974. [Full Text] [PDF] |
||||
![]() |
A. Fernandez, J. M. Schmidt, J. Claassen, M. Pavlicova, D. Huddleston, K. T. Kreiter, N. D. Ostapkovich, R. G. Kowalski, A. Parra, E. S. Connolly, et al. Fever after subarachnoid hemorrhage: Risk factors and impact on outcome Neurology, March 27, 2007; 68(13): 1013 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Singhal, M. A. Topcuoglu, D. J. Dorer, C. S. Ogilvy, B. S. Carter, and W. J. Koroshetz SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage Neurology, March 22, 2005; 64(6): 1008 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Biondi, G. K. Ricciardi, L. Puybasset, L. Abdennour, M. Longo, J. Chiras, and R. Van Effenterre Intra-Arterial Nimodipine for the Treatment of Symptomatic Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Preliminary Results AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 1067 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Commichau, N. Scarmeas, and S. A. Mayer Risk factors for fever in the neurologic intensive care unit Neurology, March 11, 2003; 60(5): 837 - 841. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |